WHWK
Whitehawk Therapeutics Inc.

6,457
Mkt Cap
$97.56M
Volume
266,895.00
52W High
$3.81
52W Low
$1.39
PE Ratio
15.24
WHWK Fundamentals
Price
$2.07
Prev Close
$2.10
Open
$2.10
50D MA
$2.08
Beta
0.98
Avg. Volume
4.53M
EPS (Annual)
-$2.36
P/B
0.62
Rev/Employee
$649,575.00
Loading...
Loading...
News
all
press releases
Whitehawk Therapeutics (NASDAQ:WHWK) Releases Quarterly Earnings Results, Beats Estimates By $0.25 EPS
Whitehawk Therapeutics (NASDAQ:WHWK - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights PR Newswire...
PR Newswire·3d ago
News Placeholder
Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC
Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC Whitehawk Therapeutics Presents Real-World...
PR Newswire·16d ago
News Placeholder
Tempus AI Fuels Growth Through Strategic Biotech Collaborations
TEM expands its AI-driven growth with new collaborations in oncology, neurogenomics, and diagnostic innovation.
Zacks·23d ago
News Placeholder
Whitehawk Therapeutics Stock Rallies 25% On Tempus AI Collaboration Deal: Retail Hopes For A Rally Toward $5 Mark
Under the deal, Whitehawk Therapeutics will apply Tempus’ real-world dataset, including, de-identified multimodal database, to support its clinical trial designs.
Stocktwits·24d ago
News Placeholder
Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a multi-year collaboration with Whitehawk Therapeutics, Inc. (NASDAQ...
Business Wire·24d ago
News Placeholder
Implied Volatility Surging for Whitehawk Therapeutics Stock Options
Zacks·5mo ago

Latest WHWK News

View

Advertisement|Remove ads.

Advertisement|Remove ads.